Screener
Ligand Pharmaceuticals LGND Kyprolis — Total revenues and income
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Royalties | ||||
| Filspari | $13,567 | $6,578 | $24,889 | $11,879 |
| Kyprolis | 7,044 | 8,803 | 13,784 | 13,526 |
| Ohtuvayre | 4,144 | 2,084 | 7,131 | 3,496 |
| Rylaze | 3,201 | 2,864 | 6,422 | 5,983 |
| Capvaxive | 2,316 | 2,250 | 4,285 | 3,135 |
| Vaxneuvance | 1,351 | 2,643 | 2,961 | 3,928 |
| Teriparatide injection | 1,470 | 2,298 | 2,791 | 3,489 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's kyprolis — total revenues and income?
- Ligand Pharmaceuticals (LGND) reported kyprolis — total revenues and income of $7.04M in Q2 2026.
- How has Ligand Pharmaceuticals's kyprolis — total revenues and income changed year-over-year?
- Ligand Pharmaceuticals's kyprolis — total revenues and income decreased by 20.0% year-over-year, from $8.8M to $7.04M.
- What does kyprolis — total revenues and income mean?
- This metric represents the aggregate financial inflows generated by the Kyprolis product line, including both core product sales and associated licensing or milestone income. It serves as a comprehensive indicator of the total economic value derived from this specific pharmaceutical asset within the company's portfolio. Monitoring this figure helps investors assess the overall commercial performance and lifecycle maturity of the product.
Ask your AI about Ligand Pharmaceuticals's kyprolis — total revenues and income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude